Accelerate to discover

Back to filter

Related topics

IncuCyte webinar: high throughput approach to developing T- Cell immunotherapies

Sartorius

Jun 17, 2019

Immunotherapy for cancers involves artificially prompting the immune system to treat cancer. Many cancer cells have...

Low-dose imaging in a new preclinical total-body PET/CT scanner

Bruker Biospin

Jun 12, 2019

Ionizing radiation constitutes a health risk to imaging scientists and study animals. Both PET and CT produce ionizing...

New insight into Cas9 off-target activity

LUMICKS

Jun 7, 2019

Scientists at the MRC London Institute of Medical Sciences and AstraZeneca studied how CRISPR-Cas9 differentiates...

Join the AVANCE Track & Keep your MRI on Track

Bruker Biospin

Jun 4, 2019

Your research depends on the scientific advances that you make with your MRI instrument. Take your instrument and your...

Jun 18, 2019

A novel method for isolating high-quality UHMW DNA from animal and human tissues

BioNano Genomics

May 31, 2019

New isolation protocol for isolating high-quality UHMW DNA from 10 mg of freshly frozen or liquid-preserved animal and...

Assessment of myocardial dynamics using photoacoustics & cardiac elastography

VisualSonics FujiFilm

May 17, 2019

Are you interested in Principles of Photoacoustic (PA) Imaging, and its application in cardiovascular research? Don’t...

Webinar recording: Detecting cancer-associated structural variants using Bionano optical maps

BioNano Genomics

May 15, 2019

Bionano’s genome mapping technology directly observes long molecules from 150,000 bp to megabase pair lengths to...

Jun 18, 2019

PET/CT Si78: Versatility in microCT dose, speed, & resolution

Bruker Biospin

May 9, 2019

The Bruker PET/CT Si78 now pairs total-body PET and SkyScan microCT technology. This combination offers the advanced...

Show all topics (10)

3R Compliant drug development studies

Jun 8, 2018

Using an ultrasound instrument, animal throughput can be low and operators also need to be highly experienced simply to even find certain organs.

At the Center for Molecular Oncology at Barts Cancer Institute, Queen Mary University of London, researchers have been using preclinical imaging to look at the pharmacokinetics of radiopharmaceuticals, to perform anatomical studies, and to assess treatment responses in mice. The center is fully equipped for radiopharmaceutical development and houses a number of imaging instruments.

One of those instruments is the ICON 1 T MRI from Bruker. In a recent interview, team leader Dr. Jane Sosabowski, explained how the molecular imaging team have been using the ICON to investigate orthotopic pancreatic tumors in mice and described some of the advantages of using this over ultrasound.

Do you want to learn more? Read the whole article!

Scientific paper
Application

Related technologies: Magnetic resonance imaging

Get more info

Miroslav Vecheta

Support specialist

Miroslav

Vecheta

+420 255 700 886

Send Message

Brand profile

Bruker Biospin

Bruker is a performace leader in preclinical imaging instrumentation. Bruker offers nine imaging modalities: PET, SPECT, CT, MRI, MPI, fluorescence, luminiscence, radioisotipic imaging and X-ray.

Related products

Bruker’s easy-to-use and cryogen-free high-performance compact MRI desktop system brings MRI within everyone’s reach

show detail

We supply and support Life-Science Technologies in the territory of Central and Eastern Europe.

Czech Republic

Slovakia

Hungary

Poland

Croatia

Slovenia

Serbia

Romania

Bulgaria

Latvia

Lithuania

Estonia

Russia

Ukraine

Belarus

Turkey